Kainova Therapeutics has dosed the first patient in Europe in [...]

Tozorakimab has met its primary endpoint in two replicate Phase [...]

Nucleome Therapeutics has appointed Michelle Morrow as chief scientific officer, [...]

Nucleome Therapeutics has nominated its first preclinical development candidate, marking [...]

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) has acquired worldwide rights [...]